Is IMA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IMA. It does not provide personalized investment advice.

IMA (ImageneBio, Inc. Common Stock) Stock Analysis - Financials

ImageneBio, Inc. Common Stock (IMA) is a publicly traded Healthcare sector company. As of November 9, 2026, IMA trades at $3.96 with a market cap of $46.60M and a P/E ratio of -0.48. IMA moved -1.58% today. Year to date, IMA is -41.49%; over the trailing twelve months it is -52.29%. Its 52-week range spans $3.88 to $18.00. Analyst consensus is buy with an average price target of $28.00. Rallies surfaces IMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are IMA's key financials?

IMA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IMA recently traded at $3.96. Market cap is $46.60M. P/E ratio is -0.48. Revenue is $800.00K.

IMA Key Metrics

Key financial metrics for IMA
Metric	Value
Price	$3.96
Market Cap	$46.60M
P/E Ratio	-0.48
EPS	$-9.64
Dividend Yield	0.00%
52-Week High	$18.00
52-Week Low	$3.88
Volume	14.66K
Avg Volume	0
Revenue (TTM)	$800.00K
Net Income	$-45.35M
Gross Margin	0.00%

IMA Analyst Consensus

1 analysts cover IMA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.00.

Common questions about IMA

What are IMA's key financials?: IMA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IMA recently traded at $3.96. Market cap is $46.60M. P/E ratio is -0.48. Revenue is $800.00K.
Is IMA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IMA. It does not provide personalized investment advice.